Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.leukres.2011.12.004PMID 22209076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How I treat adult T-cell leukemia/lymphoma.

  2011cited by this paper
• Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.

  2011cited by this paper
• Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.

  2010cited by this paper
• Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25.

  2009cited by this paper
• Current management of adult T-cell leukemia/lymphoma.

  2009cited by this paper
• Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25.

  2006cited by this paper
• CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

  2002cited by this paper
• CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

  2002cited by this paper
• Interferon α and zidovudine therapy in adult T‐cell leukaemia lymphoma: response and outcome in 15 patients

  2001cited by this paper
• Clinical significance of serum soluble IL‐2R levels in patients with adult T cell leukaemia (ATL) and HTLV‐1 carriers

  2000cited by this paper
• Advances in interleukin 2 receptor targeted treatment

  2000cited by this paper
• Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

  1999cited by this paper
• An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.

  1996cited by this paper
• Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

  1995cited by this paper
• Significance of soluble interleukin‐2 receptor levels for evaluation of the progression of adult T‐cell leukemia

  1994cited by this paper
• The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.

  1993cited by this paper
• The Epidemiology of Human T‐lymphotropic Virus Types I and II

  1993cited by this paper
• The interleukin-2 receptor: a target for immunotherapy.

  1992cited by this paper
• Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma

  1991cited by this paper
• Major prognostic factors of Japanese patients with lymphoma‐type adult T‐cell leukemia

  1990cited by this paper
• Comparison of CHOP versus VEPA Therapy in Patients with Lymphoma Type of Adult T-cell Leukemia.

  1990cited by this paper
• Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type I

  1989cited by this paper
• Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.

  1988cited by this paper
• Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.

  1985cited by this paper
• Adult T-cell lymphoma-leukaemia in Blacks from the West Indies.

  1982cited by this paper
• Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

  1981cited by this paper
• Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

  1980cited by this paper
• Adult T-cell leukemia: clinical and hematologic features of 16 cases.

  1977cited by this paper
• POSTOPERATIVE WOUND INFECTION.

  1965cited by this paper

• Targeted Therapies and Pharmacologic Advances in Mucous Membrane Pemphigoid: A Comprehensive Review

  2025cites this paper
• Advances in Techniques for the Structure and Functional Optimization of Therapeutic Monoclonal Antibodies

  2025cites this paper
• Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review

  2023cites this paper
• Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection

  2022cites this paper
• How I treat Adult T-cell leukemia/lymphoma.

  2020cites this paper
• Clinical Approaches of HIV-1/HTLV-1 Co-infection Still Keep their Mysteries

  2019cites this paper
• Combination therapy and survival time in Adult T cell Leukemia/Lymphoma (ATLL)

  2019cites this paper
• Update on diagnosis and treatment of adult T-cell leukaemia/lymphoma.

  2017cites this paper
• HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment

  2017cites this paper
• Update on diagnosis and treatment of adult T-cell leukaemia/lymphoma.

  2017cites this paper
• Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.

  2017cites this paper
• Adult T-Cell Leukemia/Lymphoma

  2017cites this paper
• Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?

  2016cites this paper
• FUNDAÇÃO OSWALDO CRUZ CENTRO DE PESQUISAS AGGEU MAGALHÃES MESTRADO EM BIOCIÊNCIAS E BIOTECNOLOGIA EM SAÚDE

  2015cites this paper
• Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?

  2015cites this paper
• Transplantation in adult T‐cell leukemia/lymphoma

  2015cites this paper
• Basiliximab (Simulect®) and Daclizumab (Zenapax®)

  2014cites this paper
• CD30 as a Therapeutic Target for Lymphoma

  2014cites this paper
• Monoclonal Antibodies: Therapeutic Uses

  2013cites this paper
• Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers

  2013cites this paper
• Clinical features of de novo CD25+ diffuse large B-cell lymphoma

  2013cites this paper
• Epidemiological Aspects and World Distribution of HTLV-1 Infection

  2012cites this paper
• Pathogenesis of Non-Hodgkin Lymphoma Derived from Infection Diseases

  2012cites this paper
• Iranian Journal of Basic Medical Sciences Comparison of Htlv-i Proviral Load in Adult T Cell Leukemia/lymphoma (atl), Htlv-i-associated Myelopathy (ham-tsp) and Healthy Carriers Htlv-i Ham/tsp Atl Htlv-i Proviral Load

  year unknowncites this paper